Cardia Bioplastics (ASX:CNN) Debt-to-Equity : 0.07 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Cardia Bioplastics Debt-to-Equity?

Cardia Bioplastics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.59 Mil. Cardia Bioplastics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.82 Mil. Cardia Bioplastics's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$20.15 Mil. Cardia Bioplastics's debt to equity for the quarter that ended in Dec. 2023 was 0.07.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Cardia Bioplastics's Debt-to-Equity or its related term are showing as below:

ASX:CNN' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.04 Med: 0.17 Max: 1.62
Current: 0.07

During the past 13 years, the highest Debt-to-Equity Ratio of Cardia Bioplastics was 1.62. The lowest was 0.04. And the median was 0.17.

ASX:CNN's Debt-to-Equity is ranked better than
87.25% of 345 companies
in the Packaging & Containers industry
Industry Median: 0.45 vs ASX:CNN: 0.07

Cardia Bioplastics Debt-to-Equity Historical Data

The historical data trend for Cardia Bioplastics's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardia Bioplastics Debt-to-Equity Chart

Cardia Bioplastics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Debt-to-Equity

Get a 7-Day Free Trial

0.14

0.17

0.07

0.09

0.08

Cardia Bioplastics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.07	0.09	0.10	0.08	0.07

Competitive Comparison of Cardia Bioplastics's Debt-to-Equity

For the Packaging & Containers subindustry, Cardia Bioplastics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cardia Bioplastics's Debt-to-Equity Distribution in the Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Cardia Bioplastics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Cardia Bioplastics's Debt-to-Equity falls into.

Cardia Bioplastics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Cardia Bioplastics's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.78	+	1.061)	/	23.133
	=	0.08

Cardia Bioplastics's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.585	+	0.815)	/	20.153
	=	0.07

Cardia Bioplastics (ASX:CNN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Cardia Bioplastics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Cardia Bioplastics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardia Bioplastics (ASX:CNN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Cardia Bioplastics Ltd (ASX:CNN) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

SES:Australia

Address

247 Ferntree Gully Road, Unit 1, Mount Waverley, Melbourne, VIC, AUS, VIC 3149

Website

https://www.secosgroup.com.au

SECOS Group Ltd is an Australian developer and manufacturer of sustainable packaging materials. . Business operating segment includes the manufacture and distribution of polyethylene films, renewable resource-based resins, and finished products. It supplies proprietary biodegradable resins, packaging products cast films to a customer base spread globally.SECOS Global Application Development Centre is in Australia. Product Development Centre and manufacturing plant for resins and finished products in China and resins plant in Malaysia. It also has manufacturing plants for cast films in Malaysia. It conducts sales via geographical regions that include Australia, Asia, America, Europe, and Africa. Asia generates maximum revenue for the company.

Cardia Bioplastics (ASX:CNN) Headlines

No Headlines